Free Trial

Northland Capmk Brokers Decrease Earnings Estimates for AXT

AXT logo with Computer and Technology background

AXT, Inc. (NASDAQ:AXTI - Free Report) - Investment analysts at Northland Capmk lowered their Q2 2025 EPS estimates for AXT in a research note issued on Monday, April 28th. Northland Capmk analyst T. Savageaux now forecasts that the semiconductor company will post earnings per share of ($0.14) for the quarter, down from their prior forecast of ($0.08). The consensus estimate for AXT's current full-year earnings is ($0.12) per share. Northland Capmk also issued estimates for AXT's Q3 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.04) EPS and FY2025 earnings at ($0.44) EPS.

AXT (NASDAQ:AXTI - Get Free Report) last announced its earnings results on Thursday, February 20th. The semiconductor company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.08). AXT had a negative return on equity of 5.27% and a negative net margin of 11.70%. The firm had revenue of $25.11 million for the quarter, compared to the consensus estimate of $23.94 million.

A number of other research analysts have also recently issued reports on AXTI. Needham & Company LLC reiterated a "buy" rating and set a $5.00 price objective on shares of AXT in a report on Friday, February 21st. B. Riley reiterated a "buy" rating and set a $6.00 price objective (up from $5.50) on shares of AXT in a report on Friday, February 21st. Wedbush reiterated an "outperform" rating and set a $4.50 price objective on shares of AXT in a report on Tuesday. Finally, StockNews.com upgraded shares of AXT to a "sell" rating in a report on Friday, April 25th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $5.13.

Read Our Latest Report on AXTI

AXT Trading Down 4.3 %

AXTI opened at $1.35 on Wednesday. AXT has a 1-year low of $1.13 and a 1-year high of $4.23. The company has a market cap of $61.56 million, a P/E ratio of -4.82 and a beta of 2.36. The company has a fifty day moving average price of $1.46 and a two-hundred day moving average price of $1.95.

Institutional Trading of AXT

Institutional investors and hedge funds have recently modified their holdings of the business. Pacific Ridge Capital Partners LLC increased its position in shares of AXT by 65.4% during the fourth quarter. Pacific Ridge Capital Partners LLC now owns 1,937,424 shares of the semiconductor company's stock valued at $4,204,000 after acquiring an additional 766,122 shares during the last quarter. Empowered Funds LLC increased its position in AXT by 5.2% in the fourth quarter. Empowered Funds LLC now owns 145,664 shares of the semiconductor company's stock worth $316,000 after buying an additional 7,165 shares during the last quarter. Bleakley Financial Group LLC bought a new position in shares of AXT in the fourth quarter worth $29,000. Geode Capital Management LLC boosted its stake in AXT by 1.7% during the third quarter. Geode Capital Management LLC now owns 464,022 shares of the semiconductor company's stock valued at $1,123,000 after buying an additional 7,577 shares during the period. Finally, Barclays PLC bought a new stake in AXT during the third quarter valued at $85,000. 49.52% of the stock is owned by hedge funds and other institutional investors.

About AXT

(Get Free Report)

AXT, Inc designs, develops, manufactures, and distributes compound and single element semiconductor substrates. The company offers indium phosphide for use in data center connectivity using light/lasers, high-speed data transfer in data centers, 5G communications, fiber optic lasers and detectors, consumer devices, passive optical networks, silicon photonics, photonic integrated circuits, thermo-photovoltaics, RF amplifier and switching, infrared light-emitting diode (LEDS) motion control, lidar for robotics and autonomous vehicles, and infrared thermal imaging.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AXT Right Now?

Before you consider AXT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AXT wasn't on the list.

While AXT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines